March 2022 Update on GeoVax Labs, Inc. (GOVX-NASDAQ) Crystal Research Associates has issued a 15-page Quarterly Update on clinical-stage biotechnology company, ... Karen Goldfarb March 14, 2022 at 6:22 PM
November 2021 Update on GeoVax Labs, Inc. (GOVX-NASDAQ) Crystal Research Associates has issued a 13-page Quarterly Update on clinical-stage biotechnology company, ... Karen Goldfarb November 17, 2021 at 9:28 AM
GeoVax Enters Agreement with PNP Therapeutics for Solid Tumor Treatment Crystal Research Associates has issued a 6-page update on clinical-stage biotechnology company, GeoVax Labs, ... Karen Goldfarb October 4, 2021 at 11:13 AM
August 2021 Update on GeoVax Labs, Inc. (GOVX-NASDAQ) Crystal Research Associates has issued a 15-page Quarterly Update on clinical-stage biotechnology company, ... Karen Goldfarb August 15, 2021 at 6:35 PM
May 2021 Update on GeoVax Labs, Inc. (GOVX-NASDAQ) Crystal Research Associates has issued an 16-page Quarterly Update on clinical-stage biotechnology company, ... Karen Goldfarb May 11, 2021 at 3:59 PM
March 2021 Update on GeoVax Labs, Inc. (GOVX-NASDAQ) Crystal Research Associates has issued an 14-page Quarterly Update on clinical-stage biotechnology company, ... Karen Goldfarb March 29, 2021 at 2:53 PM
February 2021 Update on GeoVax Labs, Inc. (GOVX-NASDAQ) Crystal Research Associates has issued an 11-page Quarterly Update on clinical-stage biotechnology company, ... Karen Goldfarb February 16, 2021 at 10:13 AM
November 2020 Update on GeoVax Labs, Inc. (GOVX-NASDAQ) Crystal Research Associates has issued a 12-page Quarterly Update on clinical-stage biotechnology company, ... Karen Goldfarb November 11, 2020 at 10:24 AM
July 2020 Update on FSD Pharma Inc. (HUGE-NASDAQ/HUGE-CSE) Crystal Research Associates has issued an 11-page Quarterly Update on specialty biotech pharmaceutical ... Karen Goldfarb July 10, 2020 at 12:15 PM
New Research Released on CEL-SCI Corporation (CVM-NYSE) An Executive Informational Overview (EIO) is now available on CEL-SCI Corporation, a clinical-stage ... Karen Goldfarb June 3, 2020 at 12:34 PM